Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B T Colvin

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Lancet (London, England)|September 10, 1994
Thrombogenic potential of factor XI concentrateP H Bolton-Maggs, B T Colvin, B T Satchi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Clinical and Laboratory Haematology|January 1, 1981
Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin timeN K Shinton, A L Bloom, B T Colvin, et al.
Clinical and Laboratory Haematology|January 1, 1986
Heat-treated NHS factor VIII concentrate in the United Kingdom--a preliminary studyB T Colvin, M Ainsworth, S J Machin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Clinical experience with a highly purified factor IX concentrate in patients undergoing surgical operationsD P Thomas, C A Lee, B T Colvin, et al.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Journal of Clinical Pathology|December 1, 1993
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for HaematologyB T Colvin, S J Machin, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Lancet (London, England)|September 10, 1994
Thrombogenic potential of factor XI concentrateP H Bolton-Maggs, B T Colvin, B T Satchi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2008
European principles of haemophilia careB T Colvin, J Astermark, K Fischer, et al.
Clinical and Laboratory Haematology|January 1, 1981
Tentative protocol for the evaluation of coagulometers, based on one-stage prothrombin timeN K Shinton, A L Bloom, B T Colvin, et al.
Clinical and Laboratory Haematology|January 1, 1986
Heat-treated NHS factor VIII concentrate in the United Kingdom--a preliminary studyB T Colvin, M Ainsworth, S J Machin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Clinical experience with a highly purified factor IX concentrate in patients undergoing surgical operationsD P Thomas, C A Lee, B T Colvin, et al.
Thrombosis and Haemostasis|February 1, 1997
HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working PartyC R Hay, W Ollier, L Pepper, et al.
Journal of Clinical Pathology|December 1, 1993
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for HaematologyB T Colvin, S J Machin, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|May 6, 1998
Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors OrganisationC R Hay, C A Ludlam, B T Colvin, et al.
Pageof 6